Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

InvEstigation of the Safety and Performance of the NVT ALLEGRA Plus THV SysteM in Patients With Severe aortIc Stenosis or Failed suRgical Aortic bioprosthEsis

NCT05804903 is registered in ClinicalTrials.gov with NVT GmbH as lead sponsor.

NCT NCT05804903
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05804903 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
InvEstigation of the Safety and Performance of the NVT ALLEGRA Plus THV SysteM in Patients With Severe aortIc Stenosis or Failed suRgical Aortic bioprosthEsis
Lead sponsor
NVT GmbH
Phase
Not applicable
Overall status
Suspended
Start date
November 24, 2023
Completion date
August 1, 2030
Enrollment
177 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

transcatheter aortic valve implantation